A process that modulates the frequency, rate or extent of the sensory perception of pain, the series of events required for an organism to receive a painful stimulus, convert it to a molecular signal, and recognize and characterize the signal, in a different organism.

Any process that stops, prevents, or reduces the frequency, rate or extent of a neurophysiological process.

A process that begins with venom being forced into an organism by the bite or sting of another organism, and ends with the inhibition of the sensory perception of pain in the bitten organism.

A process that begins with venom being forced into an organism by the bite or sting of another organism, and ends with the modulation of the sensory perception of pain in the bitten organism.

The process which begins with venom being forced into an organism by the bite or sting of another organism, and ends with the manifestation of some change or damage to the bitten organism.

The directed movement of proteins into an intracellular organelle, across a membrane.

The directed movement of a protein to a specific location on or in an organelle. Encompasses establishment of localization in the membrane or lumen of a membrane-bounded organelle.

The regulated release of vasopressin from secretory granules into the blood.

Any process involved in the maintenance of an internal steady state of water within an organism or cell.

Any biological process involved in the maintenance of an internal steady state of a chemical.

OBSOLETE. Extreme immunological sensitivity of the body or tissues to the reintroduction of an antigen. It is a form of anamnestic reaction and is accompanied by pathological changes in tissues or organs due to the release of pharmacologically active substances.

OBSOLETE. A major histocompatibility complex class I receptor. These display processed antigens from the endocytosed bacteria. MHC class I proteins can form complexes with processed antigen peptides only if the antigen is synthesized in the same cell. As a consequence, T lymphocytes can only bind to class-I-positive cells that are synthesizing the antigen (e.g. virus-infected cells).

Combining with a MHC class I molecule of the HLA-A subclass to mediate signaling that inhibits activation of a lymphocyte.

Combining with a MHC class I molecule of the HLA-A subclass to mediate signaling that activates a lymphocyte.

Combining with a MHC class I protein complex to mediate signaling that activates a lymphocyte.

Binding to a neurotrophin TRKC receptor.

Combining with a MHC class I molecule of the HLA-B subclass to mediate signaling that inhibits activation of a lymphocyte.

Binding to an hepatocyte growth factor receptor.

Binding to a vascular endothelial growth factor receptor.

Binding to a stem cell factor receptor (SCFR), a type III transmembrane kinase receptor.